HUTCHMED to Announce 2026 Half-Year Financial Results

Rhea-AI Summary

HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) will announce its 2026 half-year financial results for the six months ended June 30, 2026, on Thursday, July 30, 2026, at 7:00 am EDT / 12:00 noon BST / 7:00 pm HKT.

Management will host English and Chinese webcasts with Q&A for analysts and investors, accessible live and via replay on the company website.

News Market Reaction – HCM

+0.47%

+0.47% Session close to close

In the Jun 30 session, HCM gained 0.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for HUTCHMED’s 2026 half-year results and investor webcasts. Pr...

Analysis

This announcement sets the timetable for HUTCHMED’s 2026 half-year results and investor webcasts. Prior earnings-date news saw an average move of about 4.19%. The key risk is how the actual interim figures and outlook compare with expectations.

Key Figures

Interim period end: June 30, 2026 Results announcement date: July 30, 2026 Results announcement time: 7:00 am EDT / 12:00 noon BST / 7:00 pm HKT +2 more

5 metrics

Interim period end June 30, 2026 Six months ended for upcoming half-year financial results

Results announcement date July 30, 2026 Scheduled release of 2026 half-year interim results

Results announcement time 7:00 am EDT / 12:00 noon BST / 7:00 pm HKT Planned publication time of interim results

English webcast time 8:00 am EDT / 1:00 pm BST / 8:00 pm HKT Analyst and investor presentation with Q&A

Chinese webcast time 8:30 am HKT, July 31, 2026 Putonghua webcast for investors and analysts

Previous Earnings date Reports

1 past event · Latest: Feb 06 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 06	Earnings date announcement	Neutral	+4.2%	Set date and webcast details for release of 2025 final results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history shows HUTCHMED shares have previously reacted positively to earnings-date scheduling announcements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2026 on Thursday, July 30, 2026 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).

HUTCHMED management will host two webcast presentations for analysts and investors to discuss the interim results, followed by Q&A sessions. The English webcast will be held on Thursday, July 30, 2026, at 8:00 am EDT / 1:00 pm BST / 8:00 pm HKT. The Chinese (Putonghua) webcast will be held at 8:30 am HKT on Friday, July 31, 2026 (1:30 am BST / 8:30 pm EDT on Thursday, July 30, 2026).

Both webcasts will be available live via the company website at www.hutch-med.com/event/. The presentation will be available to download shortly before the webcast begins. A replay will also be available on the website shortly after the event.

About HUTCHMED

HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

CONTACTS

Investor Enquiries	+852 2121 8200 / ir@hutch-med.com
Media Enquiries
FTI Consulting –	+44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Tim Stamper	+44 7771 913 902 (Mobile) / +44 7779 436 698 (Mobile)
Brunswick – Zhou Yi	+852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Panmure Liberum	Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden	+44 20 7886 2500
Cavendish	Joint Broker
Geoff Nash / Nigel Birks	+44 20 7220 0500
Deutsche Numis	Joint Broker
Duncan Monteith / Ramin Naji	+44 20 7545 8000

FAQ

When will HUTCHMED (HCM) announce its 2026 half-year financial results?

HUTCHMED will announce its 2026 half-year financial results on Thursday, July 30, 2026. According to HUTCHMED, the release is scheduled for 7:00 am EDT, 12:00 noon BST, and 7:00 pm HKT, covering the six months ended June 30, 2026.

What time is HUTCHMED's English webcast for the 2026 half-year results?

The English webcast will be held on July 30, 2026, at 8:00 am EDT. According to HUTCHMED, this corresponds to 1:00 pm BST and 8:00 pm HKT, and will include a management presentation followed by a Q&A session for analysts and investors.

When is HUTCHMED's Chinese webcast for the 2026 interim results and what are the times?

The Chinese (Putonghua) webcast is scheduled for Friday, July 31, 2026, at 8:30 am HKT. According to HUTCHMED, this equals 1:30 am BST and 8:30 pm EDT on Thursday, July 30, 2026, and will also feature Q&A.

How can investors access HUTCHMED's 2026 half-year results webcasts and replay?

Investors can access the live webcasts via HUTCHMED’s website at www.hutch-med.com/event/. According to HUTCHMED, the presentation will be downloadable shortly before the webcast, and a replay will be available on the same site shortly after the event.

What period will HUTCHMED's 2026 interim financial results cover?

The 2026 interim financial results will cover the six months ended June 30, 2026. According to HUTCHMED, these half-year results will be discussed in detail during the English and Chinese webcasts, followed by question-and-answer sessions for analysts and investors.